Human disease
kidney disorder
Mondo defines it as: “A disease involving the kidney.”
1 disease group in OMIA reaches this disease, through OMIA's own Mondo link or its OMIM numbers. The page shows the chain. It does not say whether an animal is a model of this disease.
Animal diseases
By natural-model score for this disease, highest first. The score says how complete and how well supported each chain is, by stated rules. How the score works.
| OMIA group | Name | Found by | Species | The chain reached | Score |
|---|---|---|---|---|---|
| 856 | Renal disease | The group's name | 1 | Human disease |
31.5
|
Human genes
Each human gene of these disease groups that Open Targets links to this disease.
Open Targets links none of these groups' human genes to this disease.
Drugs tested for this disease
Each ChEMBL drug that has been tested for this disease, and the human genes above it acts on, if any. Open Targets gives some drugs, such as most enzyme replacement therapies, no target gene.
| Drug | Acts on | Latest stage for this disease |
|---|---|---|
| Aluminum Chlorohydrate | None of these genes | Approved |
| Aminohippuric Acid | None of these genes | Approved |
| Bumetanide | None of these genes | Approved |
| Icodextrin | None of these genes | Approved |
| Losartan | None of these genes | Approved |
| Sevelamer Hydrochloride | None of these genes | Approved |
| Calcifediol Anhydrous | None of these genes | Awaiting approval |
| Aspirin | None of these genes | Phase 3 |
| Cinacalcet | None of these genes | Phase 3 |
| Cyclophosphamide Anhydrous | None of these genes | Phase 3 |
| Empagliflozin | None of these genes | Phase 3 |
| Lisinopril Anhydrous | None of these genes | Phase 3 |
| Methylprednisolone | None of these genes | Phase 3 |
| Obinutuzumab | None of these genes | Phase 3 |
| Olmesartan Medoxomil | None of these genes | Phase 3 |
| Pentoxifylline | None of these genes | Phase 3 |
| Rituximab | None of these genes | Phase 3 |
| Roxadustat | None of these genes | Phase 3 |
| Tacrolimus Anhydrous | None of these genes | Phase 3 |
| Cyclosporine | None of these genes | Phase 2/3 |
| Everolimus | None of these genes | Phase 2/3 |
| Zanubrutinib | None of these genes | Phase 2/3 |
| Albumin Human | None of these genes | Phase 2 |
| Aliskiren | None of these genes | Phase 2 |
| Atorvastatin | None of these genes | Phase 2 |
| Belimumab | None of these genes | Phase 2 |
| Bortezomib | None of these genes | Phase 2 |
| Dexamethasone | None of these genes | Phase 2 |
| Efgartigimod Alfa | None of these genes | Phase 2 |
| Febuxostat | None of these genes | Phase 2 |
| Felzartamab | None of these genes | Phase 2 |
| Filgotinib | None of these genes | Phase 2 |
| Gemcitabine | None of these genes | Phase 2 |
| Hydrochlorothiazide | None of these genes | Phase 2 |
| Inaxaplin | None of these genes | Phase 2 |
| Isatuximab | None of these genes | Phase 2 |
| Lanraplenib | None of these genes | Phase 2 |
| Leflunomide | None of these genes | Phase 2 |
| Lenalidomide | None of these genes | Phase 2 |
| Mycophenolate Mofetil | None of these genes | Phase 2 |
| Peginterferon Alfa-2a | None of these genes | Phase 2 |
| Prednisone | None of these genes | Phase 2 |
| Semaglutide | None of these genes | Phase 2 |
| Tenapanor | None of these genes | Phase 2 |
| Voclosporin | None of these genes | Phase 2 |
| Zibotentan | None of these genes | Phase 2 |
| Furosemide | None of these genes | Phase 1/2 |
| Nesiritide | None of these genes | Phase 1/2 |
| Sildenafil | None of these genes | Phase 1/2 |
| Tesevatinib | None of these genes | Phase 1/2 |
| Aldafermin | None of these genes | Phase 1 |
| Bq-123 | None of these genes | Phase 1 |
| Darbepoetin Alfa | None of these genes | Phase 1 |
| Epoetin Alfa | None of these genes | Phase 1 |
| Epoetin Beta | None of these genes | Phase 1 |
| Evogliptin | None of these genes | Phase 1 |
| Hydroxyurea | None of these genes | Phase 1 |
| Inclisiran | None of these genes | Phase 1 |
| Nifedipine | None of these genes | Phase 1 |
| Osivelotor | None of these genes | Phase 1 |
| Sotagliflozin | None of these genes | Phase 1 |
| Niacinamide | None of these genes | Early phase 1 |
| Allopurinol | None of these genes | Unknown |
| Alogliptin | None of these genes | Unknown |
| Canagliflozin Anhydrous | None of these genes | Unknown |
| Dapagliflozin | None of these genes | Unknown |
| Dextrose | None of these genes | Unknown |
| Dulaglutide | None of these genes | Unknown |
| Enalapril | None of these genes | Unknown |
| Ertugliflozin | None of these genes | Unknown |
| Exenatide | None of these genes | Unknown |
| Glimepiride | None of these genes | Unknown |
| Glipizide | None of these genes | Unknown |
| Glyburide | None of these genes | Unknown |
| Insulin Aspart | None of these genes | Unknown |
| Insulin Degludec | None of these genes | Unknown |
| Insulin Detemir | None of these genes | Unknown |
| Insulin Glargine | None of these genes | Unknown |
| Insulin Human | None of these genes | Unknown |
| Insulin Human, Isophane | None of these genes | Unknown |
| Linagliptin | None of these genes | Unknown |
| Liraglutide | None of these genes | Unknown |
| Saxagliptin Anhydrous | None of these genes | Unknown |
| Sitagliptin | None of these genes | Unknown |
| Spironolactone | None of these genes | Unknown |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.